Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Silo Pharma (SILO) Non Operating Income (2019 - 2025)

Silo Pharma (SILO) has disclosed Non Operating Income for 7 consecutive years, with -$95006.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 214.84% to -$95006.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52964.0 through Dec 2025, down 83.07% year-over-year, with the annual reading at $52964.0 for FY2025, 83.07% down from the prior year.
  • Non Operating Income hit -$95006.0 in Q4 2025 for Silo Pharma, down from $41028.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $7.0 million in Q3 2021 to a low of -$280015.0 in Q4 2022.
  • Historically, Non Operating Income has averaged $356357.0 across 5 years, with a median of $55363.0 in 2021.
  • Biggest five-year swings in Non Operating Income: crashed 339.78% in 2021 and later soared 35954.42% in 2023.
  • Year by year, Non Operating Income stood at -$143116.0 in 2021, then plummeted by 95.66% to -$280015.0 in 2022, then surged by 140.05% to $112148.0 in 2023, then decreased by 26.23% to $82732.0 in 2024, then tumbled by 214.84% to -$95006.0 in 2025.
  • Business Quant data shows Non Operating Income for SILO at -$95006.0 in Q4 2025, $41028.0 in Q3 2025, and $44258.0 in Q2 2025.